Sandra C. Patterson - 10 Mar 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Reporting relationship: SVP, Controllership
Issuer ticker: GILD
Reported as of: 10 Mar 2024
Net transaction value: -$59,345
SEC form: 4
Accepted by SEC: 12 Mar 2024, 15:57:35 UTC
Prior SEC filing: 16 Dec 2024
Next SEC filing: 11 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Amy Kim by Power of Attorney for Sandra C. Patterson

Key filing fact

Sandra C. Patterson filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 12 Mar 2024.

Key facts

This page summarizes Sandra C. Patterson's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
7 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 12 Mar 2024, 15:57.

Change

Previous filing in this sequence was filed on 16 Dec 2024.
Current net transaction value: -$59,345.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GILD transaction

Common Stock

Options Exercise

Transaction value
Shares: +748
Change %: +2.4%
Price
Shares after: 31,488
Date: 10 Mar 2024
Ownership: Direct
Footnotes: F1, F2

GILD transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,934
Change %: +6.1%
Price
Shares after: 33,422
Date: 10 Mar 2024
Ownership: Direct
Footnotes: F1

GILD transaction

Common Stock

Tax liability

Transaction value: $59,345
Shares: -790
Change %: -2.4%
Price: $75.12
Shares after: 32,632
Date: 10 Mar 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GILD transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -748
Change %: -4.5%
Price
Shares after: 15,772
Date: 10 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 748
Exercise price
Footnotes: F1, F3

GILD transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -1,934
Change %: -12%
Price
Shares after: 13,838
Date: 10 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,934
Exercise price
Footnotes: F1, F4

GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +13,660
Change %
Price: $0.000000
Shares after: 13,660
Date: 10 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,660
Exercise price: $75.12
Footnotes: F5

GILD transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares: +4,825
Change %: +35%
Price
Shares after: 18,663
Date: 10 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,825
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Footnote F2

Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.

Footnote F3

The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.

Footnote F4

The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Footnote F5

The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.